SCHEMBL2339976

SCHEMBL2339976

CC(C)(C)OC(=O)c1cc(Cl)nc(C(O)C(F)(F)F)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.36
KMT2A Q03164 1/20 0.36
SLC7A5 Q01650 1/20 0.32
STAT3 P40763 1/20 0.32
HSP90AA1 P07900 1/20 0.32
HSP90AB1 P08238 1/20 0.32
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA9 Q16790 1/20 0.31
CA14 Q9ULX7 1/20 0.31
CNR1 P21554 1/20 0.31
CNR2 P34972 1/20 0.31
GABRB1 P18505 1/20 0.31
GABRB2 P47870 1/20 0.31
AAK1 Q2M2I8 1/20 0.31
GABRA1 P14867 1/20 0.30
GABRG2 P18507 1/20 0.30
GABRB3 P28472 1/20 0.30
GABRA3 P34903 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL454678 0.81 ALDH1A1 (0.40) LMNAKMT2ASLC7A5STAT3HSP90AA1
SCHEMBL2266170 0.80 TPMT (0.37) CA12CA1CA2CA9CA14
SCHEMBL6122289 0.77 GPBAR1 (0.40) LMNAKMT2ASTAT3HSP90AA1HSP90AB1
SCHEMBL2262167 0.75 ALPL (0.39) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL1425447 0.75 ALDH1A1 (0.39) LMNAKMT2ASTAT3HSP90AA1HSP90AB1
SCHEMBL23684086 0.74 CA12 (0.38) LMNAKMT2ASLC7A5STAT3HSP90AA1
SCHEMBL30260185 0.74 CA12 (0.38) LMNAKMT2ASLC7A5STAT3HSP90AA1
SCHEMBL2260721 0.73 STK17B (0.34) LMNAKMT2ASLC7A5STAT3HSP90AA1
SCHEMBL2711566 0.73 ALDH1A1 (0.53) LMNAKMT2ASTAT3HSP90AA1HSP90AB1
SCHEMBL20913863 0.73 ALOX15 (0.43) LMNAKMT2ASLC7A5STAT3HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2860178-B1 P2X3 receptor antagonists for treatment of pain MERCK SHARP & DOHME (US) 2021-01-13 EP disclosed
EP-2860178-A2 P2X3 receptor antagonists for treatment of pain Merck Sharp & Dohme Corp. (US) 2015-04-15 EP disclosed
EP-2358371-B1 P2X3, RECEPTOR ANTAGONISTS FOR TREATMENT OF PAIN MERCK SHARP & DOHME (US) 2015-02-11 EP disclosed
EP-2358371-A1 P2X3, RECEPTOR ANTAGONISTS FOR TREATMENT OF PAIN Merck Sharp & Dohme Corp. (US) 2011-08-24 EP disclosed
WO-2010051188-A1 P2X3, RECEPTOR ANTAGONISTS FOR TREATMENT OF PAIN MERCK SHARP & DOHME CORP. (US) 2010-05-06 WO disclosed